EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of xeno-free induced mesenchymal stem/stromal cells in enhancing autologous fat graft survival

Hideharu Nakamura, Takaya Makiguchi, Takahiro Yamaguchi, Sasagu Kurozumi, Daisuke Kamiya, Makoto Ikeya, Takaaki Fujii, Akihiko Uchiyama, Sei-Ichiro Motegi, Jun Horiguchi, Ken Shirabe, Satoshi Yokoo

Breast Cancer · 2026

DOI: 10.1007/s12282-026-01838-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer, 2026. Verfasst von Hideharu Nakamura und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, 3-39-22, Showa-cho, Maebashi, Gunma,…. Hauptthemen laut MEDLINE: Adipose Tissue, Mesenchymal Stem Cells, Graft Survival, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Division of Grants and Agreements.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Breast reconstruction using autologous fat grafting offers a less invasive alternative with shorter surgical times compared to traditional flap procedures. Although adipose-derived stem cells (ASCs) have improved fat graft survival rates, the variability in mesenchymal stem cells (MSCs) quality due to donor health and medication intake poses challenges. MSCs derived from induced pluripotent stem cells (iPSC-MSCs) demonstrate enhanced proliferative and immunomodulatory properties that may further enhance outcomes. METHODS: We harvested human adipose tissue from surgical specimens and isolated ASCs. We used human iPSC-MSCs generated through a neural crest cell lineage under xeno-free conditions (iMSCs), to assess the improvement in survival and integration of autologous human adipose tissue grafts in BALB/c-nu/ + mice. We compared outcomes in groups treated with phosphate-buffered saline (PBS), ASCs, and iMSCs over 28 days, focusing on fat graft retention, fibrosis, and neovascularization, and adipogenic differentiation using vimentin/perilipin immunofluorescence staining. RESULTS: iMSC treatment significantly preserved graft area (82.3 ± 20.5%) compared to PBS controls (50.6 ± 28.7%) and ASC treatments (65.3 ± 24.7%). It also resulted in the lowest fibrosis (7,748.7 ± 6,018.6 µm2) and highest neovascularization (68,681.5 ± 21,363.4 µm2), indicating improved tissue integration and vascularization. The proportion of vimentin-positive/perilipin-positive cells—indicative of adipogenic differentiation—was significantly higher in the iMSC group (7.46%) compared to PBS (4.51%, p = 0.025). CONCLUSION: iMSCs may enhance fat graft survival through both paracrine signaling and adipogenic differentiation, supporting a dual mechanism of action. These findings highlight their potential as a standardized, high-performance cellular adjunct for improving surgical outcomes in breast reconstruction and potentially other regenerative medicine applications. Further studies incorporating cell tracking techniques are warranted to confirm the direct differentiation potential of iMSCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adipose TissueMesenchymal Stem CellsGraft SurvivalMesenchymal Stem Cell TransplantationInduced Pluripotent Stem CellsMammaplastyHumansAnimalsFemaleMiceCell DifferentiationTransplantation, AutologousMice, Inbred BALB CMice, NudeCells, Cultured

Stichwörter der Autor:innen

Breast reconstructionFat graftingInduced pluripotent stem cellsMesenchymal stem cellsXeno-free induced mesenchymal stem/stromal cells

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, 3-39-22, Showa-cho, Maebashi, Gunma, 371-8511, Japan. hidemoku0211@gmail.com.
  • Department of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, 3-39-22, Showa-cho, Maebashi, Gunma, 371-8511, Japan.
  • Department of Breast Surgery, International University of Health and Welfare, Chiba, Japan.
  • Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
  • Department of Breast Surgery and Oncology, Nippon Medical School Hospital, Tokyo, Japan.
  • Department of Dermatology, Gunma University Graduate School of Medicine, Gunma, Japan.

Förderung

  • Division of Grants and Agreements

Zitieren

APA

Nakamura, H., Makiguchi, T., Yamaguchi, T., Kurozumi, S., Kamiya, D., Ikeya, M., Fujii, T., Uchiyama, A., Motegi, S. I., Horiguchi, J., Shirabe, K., & Yokoo, S. (2026). Efficacy of xeno-free induced mesenchymal stem/stromal cells in enhancing autologous fat graft survival. Breast Cancer. https://doi.org/10.1007/s12282-026-01838-3

Vancouver

Nakamura H, Makiguchi T, Yamaguchi T, Kurozumi S, Kamiya D, Ikeya M, et al. Efficacy of xeno-free induced mesenchymal stem/stromal cells in enhancing autologous fat graft survival. Breast Cancer. 2026. doi:10.1007/s12282-026-01838-3

BibTeX
@article{Nakamura2026,
  author = {Nakamura, Hideharu and Makiguchi, Takaya and Yamaguchi, Takahiro and Kurozumi, Sasagu and Kamiya, Daisuke and Ikeya, Makoto and Fujii, Takaaki and Uchiyama, Akihiko and Motegi, Sei-Ichiro and Horiguchi, Jun and Shirabe, Ken and Yokoo, Satoshi},
  title = {Efficacy of xeno-free induced mesenchymal stem/stromal cells in enhancing autologous fat graft survival},
  journal = {Breast Cancer},
  year = {2026},
  doi = {10.1007/s12282-026-01838-3}
}
Kostenlos starten →